News

Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.
Goldman Sachs said Monday that GSK (NYSE:GSK) is set for a 'positive surprise' this week as a CDC Advisory Committee is ...
(RTTNews) - Pfizer (PFE) announced the European Commission has issued a decision amending the marketing authorization for ABRYSVO, the company's bivalent respiratory syncytial virus prefusion F ...
Coronavirus and respiratory syncytial virus (RSV) are two kinds of respiratory viruses that can infect you and have similar symptoms. It can be hard to tell the difference between infections ...
The Allan Labor Government is keeping Victorian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting immunisation available free from tomorrow for eligible families until ...
Respiratory virus data included in the interactive data application is up-to-date as of April 5, 2025. Among its new features, the dashboard now includes RSV Severe Outcomes data.
A major challenge lies in the virus's structure and regulatory mechanisms, which have remained largely unclear. In particular, scientists have long struggled to fully understand its nucleocapsid ...
The nation’s adult vaccination coverage is low, a number not helped by conflicting official guidelines on the flu-like respiratory syncytial virus (RSV). (76% of over-60s still aren’t vaccinated for ...
A 2023–24 vaccine effectiveness analysis of immunocompetent adults aged 60 years or older in the USA showed 80% (95% CI 71–85) protection against respiratory syncytial virus (RSV)-associated hospital ...
In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...